While significant advancements in neuromodulation have created to improved patient outcomes for an expanded number of painful conditions, conditions that may be managed primarily by non pain specialists. The limited implementation and uptake of these treatments by referring providers in non-pain care specialties impacts patient access to these high impact treatments. Illustrating the gaps and barriers that impact access enables strategic development aimed at accelerating uptake of these treatments at the population and health care ecosystem level.
Upon completion of this educational activity, participants should be able to:
- Understand the gaps and barriers that limit patient access to neuromodulation services
- Discuss the strategies that accelerate uptake of neuromodulation access and utilization at the patient and population levels
- Identify partnerships between stakeholders (industry, professional societies, patient advocacy groups, and physicians) to create heightened awareness in the medical community of the role of neuromodulation.
- Illustrate the tenets of healthcare delivery science and implementation medicine and the critical need for investment by clinicians in improving care delivery systems to grow their practices while benefiting patients.
Ramana K. Naidu, MD
David Dickerson, MD
Natalie Strand, MD
Johnathan H. Goree, MD
Dawood Sayed, MD